355 results
8-K
EX-5.1
AWH
Aspira Women`s Health Inc
26 Apr 24
Other Events
5:30pm
are applicable to the subject matter hereof and express no opinion and provide no assurance as to compliance with any federal or state securities law
424B5
AWH
Aspira Women`s Health Inc
26 Apr 24
Prospectus supplement for primary offering
5:29pm
no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus supplement
424B3
AWH
Aspira Women`s Health Inc
11 Apr 24
Prospectus supplement
4:13pm
for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only
S-8
EX-5.1
e5unxxo30 p1
26 Jan 24
Registration of securities for employees
5:25pm
8-K/A
EX-10.1
e9q8m4paaw9x558
26 Jan 24
Entry into a Material Definitive Agreement
5:19pm
8-K/A
EX-1.1
5vfu6zf06x4 z5jf
26 Jan 24
Entry into a Material Definitive Agreement
5:19pm
8-K/A
EX-5.1
jsp2oymtvg1cc
26 Jan 24
Entry into a Material Definitive Agreement
5:19pm
424B5
ssghi5c95z dvugzd
26 Jan 24
Prospectus supplement for primary offering
5:12pm
8-K
EX-10.1
ndv9l
25 Jan 24
Entry into a Material Definitive Agreement
5:31pm
8-K
EX-1.1
gzuaz qrtbiog
25 Jan 24
Entry into a Material Definitive Agreement
5:31pm
8-K
EX-5.1
tqm3e hws
25 Jan 24
Entry into a Material Definitive Agreement
5:31pm
8-K
EX-99.1
qdom2qsxg o451u2b7jp
6 Dec 23
Aspira Women’s Health Provides a Development Update on its Portfolio of Noninvasive Tests for Endometriosis
4:43pm